RxDoctor Payments Data

Charity Douglas

Nurse Practitioner · Corbin, KYNPI 1265904890

Payments from drug & device makers

$4,823in general payments, 2019–2025

Across 258 payments — averaging $18.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$1K
  • Pfizer$860
  • Eko Health, Inc.$549
  • Merck$540
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$282
  • AstraZeneca$270
  • plus $1K from 16 others

What the payments were for

  • Speaking & faculty fees$2004%
  • Food & beverage$4,16486%
  • Education$1102%
  • Other$3497%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,823 in reported general payments places this provider in the 90th percentile of 1,918 nurse practitioner providers in Kentucky.

See all nurse practitioner providers in Kentucky

Medicare billing

Part B allowed, 2024
$35,053
Medicare patients
194
Services billed
423

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban398$334,498
Repatha SureclickEvolocumab122$145,942
EntrestoSacubitril/Valsartan82$74,000
XareltoRivaroxaban57$48,061
JardianceEmpagliflozin28$28,996
Praluent PenAlirocumab21$24,101
BrilintaTicagrelor44$19,354
WegovySemaglutide12$15,854
Ranolazine ErRanolazine116$11,535
Flecainide Acetate89$3,113
Rosuvastatin Calcium288$2,671
Metoprolol Succinate202$1,789
Midodrine Hcl20$1,137
Atorvastatin Calcium207$996
Isosorbide Mononitrate ErIsosorbide Mononitrate187$918

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$860$334,498398 claims
NovartisEntresto$1,050$74,00082 claims
Johnson & JohnsonXarelto$160$48,06157 claims
Boehringer IngelheimJardiance$75$28,99628 claims
AstraZenecaBrilinta$270$19,35444 claims
Novo NordiskWegovy$115$15,85412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,918 nurse practitioner providers in Kentucky.

Other nurse practitioner in Corbin

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →